Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
about
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future DirectionsAcute kidney injury: preclinical innovations, challenges, and opportunities for translationHepatic Encephalopathy: From the Pathogenesis to the New Treatments.Management of Neurologic Manifestations in Patients with Liver Disease.Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary.Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France.Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patientsUseful tests for hepatic encephalopathy in clinical practice.Managing complications in cirrhotic patientsClinical science workshop: targeting the gut-liver-brain axis.Hepatic encephalopathy: a critical current review.Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy.An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.The Pharmabiotic Approach to Treat Hyperammonemia.Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?Phenylbutyrate exerts adverse effects on liver regeneration and amino acid concentrations in partially hepatectomized rats.Where are we going? Translational research in hepatic encephalopathy.Hypothesis: Role for ammonia neutralization in the prevention and reversal of heart failure.Hepatic encephalopathy: current challenges and future prospects.Update on the Therapeutic Management of Hepatic Encephalopathy.Hepatic encephalopathy
P2860
Q26744689-DD1C58A6-F3B2-4F71-BCD3-D6C35C1B6F2AQ26786667-1347074F-E3F2-45FB-8CC4-167344ECF095Q30381016-96111DC7-AEE4-474D-95C4-79EDB0CE52DBQ31108752-79E211FD-D127-4B94-8341-AEFA4CCAAB7DQ33805285-34C07604-D164-4312-A4AD-F834A12277ACQ34509599-B6C412A3-3DE0-46BE-B7D6-4129E68FE2F1Q34530153-7741873E-5A95-4B6C-8027-B4C07BD4F544Q37019499-2F3699B8-902E-47F8-ABEE-C94825B9D495Q37361451-5846AD2C-66B1-47DA-9A82-F7D974F99807Q38172872-DD5CC4F7-1C7E-47BF-907F-9CC69887BC0FQ38344890-C3632B7B-39AA-4BF3-9DB4-080E713129CAQ38601692-184575E9-5BBA-4D05-A874-0272DCCDC3ACQ38645107-EADB4D9C-B3FA-4327-9A62-760CBC31F178Q38835093-D69EA2BC-2686-44BE-8820-DE71431354C9Q39012545-A33C3E8F-4CB6-4CEA-B430-66077AF1C985Q39658369-043A51AD-26CE-40E3-A428-C732082AC9E2Q47312982-F8D77F94-5F37-4D8A-A22C-CE34290A7D87Q47831420-20720BB4-6485-48AC-8B27-FD8A0302DA54Q48245085-7AB6A8AB-BB74-4EFB-8993-4773C94BF96FQ51661337-D0997845-C428-49AC-8F88-B88B002636E5Q52149705-4E010698-25A0-4200-ADAB-53D5B93022AAQ52652520-55F9BAA9-258D-4D80-8855-5D9D298D2663Q54243938-085A7293-D5CE-4BF1-95B0-29B09BE9B022Q55312369-FFAC8E0D-E2F3-4038-84AD-D62DD85FFA57Q56456330-EA15569A-E72E-48EA-AF63-A2CAB0CCB162
P2860
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Randomized, double-blind, cont ...... ate in hepatic encephalopathy.
@ast
Randomized, double-blind, cont ...... ate in hepatic encephalopathy.
@en
type
label
Randomized, double-blind, cont ...... ate in hepatic encephalopathy.
@ast
Randomized, double-blind, cont ...... ate in hepatic encephalopathy.
@en
prefLabel
Randomized, double-blind, cont ...... ate in hepatic encephalopathy.
@ast
Randomized, double-blind, cont ...... ate in hepatic encephalopathy.
@en
P2093
P2860
P50
P356
P1433
P1476
Randomized, double-blind, cont ...... rate in hepatic encephalopathy
@en
P2093
Andrey Baranovsky
Bruce F Scharschmidt
Catherine Norris
Dion Coakley
Don C Rockey
HALT-HE Study Group
Iryna Klaryts'ka
John M Vierling
K Gautham Reddy
K Rajender Reddy
P2860
P304
P356
10.1002/HEP.26611
P407
P577
2014-03-01T00:00:00Z